Citation: P. Finne et al., Neural network analysis of clinicopathological factors in urological disease: a critical evaluation of available techniques, BJU INT, 88(8), 2001, pp. 825-831
Authors:
Vartiainen, J
Lehtovirta, P
Finne, P
Stenman, UH
Alfthan, H
Citation: J. Vartiainen et al., Preoperative serum concentration of hCG beta as a prognostic factor in ovarian cancer, INT J CANC, 95(5), 2001, pp. 313-316
Authors:
Stenman, J
Hedstrom, J
Grenman, R
Leivo, I
Finne, P
Palotie, A
Orpana, A
Citation: J. Stenman et al., Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck, INT J CANC, 95(1), 2001, pp. 39-43
Authors:
Andersen, JM
Hedstrom, J
Kemppainen, E
Finne, P
Puolakkainen, P
Stenman, UH
Citation: Jm. Andersen et al., The ratio of trypsin-2-alpha(1)-antitrypsin to trypsinogen-1 discriminatesbiliary and alcohol-induced acute pancreatitis, CLIN CHEM, 47(2), 2001, pp. 231-236
Authors:
Lempinen, M
Kylanpaa-Back, ML
Stenman, UH
Puolakkainen, P
Haapiainen, R
Finne, P
Korvuo, A
Kemppainen, E
Citation: M. Lempinen et al., Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine, CLIN CHEM, 47(12), 2001, pp. 2103-2107
Authors:
Finne, P
Finne, R
Auvinen, A
Juusela, H
Aro, J
Maattanen, L
Hakama, M
Rannikko, S
Tammela, TLJ
Stenman, UH
Citation: P. Finne et al., Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network, UROLOGY, 56(3), 2000, pp. 418-422
Citation: Wm. Zhang et al., Determination of prostate-specific antigen complexed to alpha(2)-macroclobulin in serum increases the specificity of free to total PSA for prostate cancer, UROLOGY, 56(2), 2000, pp. 267-272
Authors:
Zhang, WM
Finne, P
Leinonen, J
Stenman, UH
Citation: Wm. Zhang et al., Characterization and determination of the complex between prostate-specific antigen and alpha(1)-protease inhibitor in benign and malignant prostaticdiseases, SC J CL INV, 60, 2000, pp. 51-58
Authors:
Finne, P
Zhang, WM
Auvinen, A
Leinonen, J
Maattanen, L
Rannikko, S
Tammela, TLJ
Stenman, UH
Citation: P. Finne et al., Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer, J UROL, 164(6), 2000, pp. 1956-1960
Authors:
Finne, P
Auvinen, A
Koistinen, H
Zhang, WM
Maattanen, L
Rannikko, S
Tammela, T
Seppala, M
Hakama, M
Stenman, UH
Citation: P. Finne et al., Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen, J CLIN END, 85(8), 2000, pp. 2744-2747
Authors:
Rutanen, EM
Hurskainen, R
Finne, P
Nokalainen, K
Citation: Em. Rutanen et al., Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia, FERT STERIL, 73(5), 2000, pp. 1020-1024
Authors:
Hedstrom, J
Grenman, R
Ramsay, H
Finne, P
Lundin, J
Haglund, C
Alfthan, H
Stenman, UH
Citation: J. Hedstrom et al., Concentration of free hCG beta subunit in serum as a prognostic marker forsquamous-cell carcinoma of the oral cavity and oropharynx, INT J CANC, 84(5), 1999, pp. 525-528
Authors:
Zhang, WM
Finne, P
Leinonen, J
Vesalainen, S
Nordling, S
Stenman, UH
Citation: Wm. Zhang et al., Measurement of the complex between prostate-specific antigen and alpha(1)-protease inhibitor in serum, CLIN CHEM, 45(6), 1999, pp. 814-821
Authors:
Zhang, WM
Finne, P
Leinonen, J
Vesalainen, S
Nordling, S
Rannikko, S
Stenman, UH
Citation: Wm. Zhang et al., Characterization and immunological determination of the complex between prostate-specific antigen and alpha(2)-macroglobulin, CLIN CHEM, 44(12), 1998, pp. 2471-2479